Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
TORONTO and ATHENS, Greece, July 22, 2019 (GLOBE NEWSWIRE) -- Global Cannabis Corp. (“GCC” or the “Company”) and its partner SLANG Worldwide Inc. (CNSX: SLNG), (Frankfurt: 84S), ("SLANG") are...
TORONTO, July 18, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a leading Latin American licensed producer of medicinal...
TORONTO, June 11, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) ("Blueberries"), a leading Latin American licensed producer of medicinal cannabis and...
RNS Number:9452S Slingsby(H.C.)Plc 05 December 2003 HC SLINGSBY PLC HOLDING IN THE COMPANY The Company has been notified today that in accordance with section 198 of the...
RNS Number:7358R Slingsby(H.C.)Plc 05 November 2003 HC SLINGSBY PLC ("THE COMPANY") Notifiable Interest and Directors' Shareholdings The Company has been notified today that, in...
RNS Number:2025Q Slingsby(H.C.)Plc 26 September 2003 H C Slingsby plc Report for the half year ended 30 June 2003 Statement by the Chairman Although it is disappointing to report...
RNS Number:4061K Slingsby(H.C.)Plc 25 April 2003 H C SLINGSBY PLC Preliminary announcement for the year to 31 December 2002 Statement by the Chairman It is satisfying to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.015 | 0.02 | 0.01 | 119947 | 0.01069523 | CS |
| 4 | -0.015 | -50 | 0.03 | 0.035 | 0.005 | 134251 | 0.01602501 | CS |
| 12 | -0.015 | -50 | 0.03 | 0.045 | 0.005 | 115322 | 0.02586904 | CS |
| 26 | -0.04 | -72.7272727273 | 0.055 | 0.07 | 0.005 | 89334 | 0.02815499 | CS |
| 52 | -0.145 | -90.625 | 0.16 | 0.45 | 0.005 | 109208 | 0.07174434 | CS |
| 156 | -0.845 | -98.2558139535 | 0.86 | 1.03 | 0.005 | 288229 | 0.2588195 | CS |
| 260 | 0 | 0 | 0 | 0.015 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
